Peng Zhao

Title: The Innovative Contributions of Peng Zhao

Introduction

Peng Zhao is a prominent inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of biomedical research, particularly in the development of novel therapeutic agents. With a total of 3 patents to his name, Zhao's work focuses on innovative solutions for cancer treatment.

Latest Patents

Zhao's latest patents include groundbreaking technologies that utilize immune-tolerant elastin-like peptides. One of his notable inventions is the "Immune tolerant elastin-like peptide tetramer guided nanoparticles and methods of use." This patent discloses nanoparticles that comprise immune-tolerant elastin-like polypeptide tetramers and fusion molecules. The invention also details pharmaceutical compositions that include these nanoparticles, along with methods for administering them to patients for cancer treatment.

Another significant patent is the "Immune tolerant and non-immune tolerant elastin-like recombinant peptides and methods of use." This invention describes recombinant polypeptides with homologous amino acid repeats and non-immunogenic bioconjugates. It also includes pharmaceutical compositions and methods for administering these peptides to patients for treating cancer or infections.

Career Highlights

Peng Zhao is affiliated with the University of Utah Research Foundation, where he conducts his research and develops his innovative technologies. His work has garnered attention for its potential impact on cancer therapies and treatment methodologies.

Collaborations

Zhao collaborates with esteemed colleagues, including Mingnan Chen and Hyung Jin Cho, to further advance his research and innovations in the field.

Conclusion

Peng Zhao's contributions to biomedical research and his innovative patents highlight his commitment to improving cancer treatment options. His work continues to pave the way for future advancements in therapeutic technologies.